Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes (EMERALD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by University of Colorado, Denver
Sponsor:
Collaborators:
American Diabetes Association
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01808690
First received: March 6, 2013
Last updated: June 16, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)